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ABSTRACT
Background: Increased concentrations of  tumor necrosis 
factor alpha (TNF‑α) in blood and amniotic fluid are observed 
in women with preterm delivery (PTD) and TNF‑α mutations 
at  −308  position  are  associated  with  higher  expression  of   this 
gene. Therefore, we compared the frequency of  G308A transition 
in  the promoter  region of  TNF‑α  gene of  women and neonates 
delivered preterm with the normal subjects.
Methods: This cross‑sectional study was performed on 
135  mothers  who  were  referred  for  delivery.  According  to  the 
gestational  age,  mothers  and  their  neonates  were  allocated  to 
the  case  (preterm,  64  subjects)  and  control  (term,  71  subjects) 
groups. Using the polymerase chain reaction, restrictive fragment 
length polymorphism (RFLP), genotyping was performed on both 
maternal peripheral blood and cord blood samples to determine 
single nucleotide polymorphism in the promoter region of  TNF‑α 
gene at –308.
Results: Two  mothers  in  the  case  group,  one  mother  in  the 
control group and one neonate in the case group had genotyping 
assays (GA) mutation. All other subjects had normal GG genotype. 
Frequency of  GA mutation was not significantly different between 
two groups (P = 0.47).
Conclusions: There  is  no  significant  association  between  PTD 
and either maternal or fetal TNF‑α  −308  polymorphism  and 
frequency ofGAmutation is not significantly increased in mothers 
and  neonates  delivered  preterm.  It  means  that  the  presence  of  
this mutation by  itself  does not modify  the overall  risk of  PTD. 
Investigations  on  the  combination  of   various  polymorphisms 
indifferent  genes  are  recommended  to  achieve  more  accurate 
results.
Keywords:  Genetics,  mutation,  polymorphism,  preterm  birth, 
tumor necrosis factor alpha
INTRODUCTION
Preterm delivery (PTD) is a major public health problem 
world‑wide, which may lead to severe complications such 
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as cerebral palsy, chronic respiratory disease, 
blindness and neuro‑developmental delay. It is also 
one of  the main causes of  perinatal and neonatal 
death[1‑3] and imposes a large economic burden on 
the health‑care system.[4,5]
Increased rate of  PTD in women who had 
PTD, high probability of  PTD in women with a 
previous history of  PTD and studies of  pregnancy 
outcomes in twins suggest that genetic factors may 
be important determinants of  PTD.[2,6]
In addition, previous studies suggest that the 
inflammation caused by subclinical genital tract 
infection may be associated with PTD.[7,8]
Increased concentration of  proinflammatory 
cytokines has been found in amniotic fluid, maternal 
and fetal blood of  a significant number of  women 
with PTD.[9‑15] Tumor necrosis factor‑α (TNF‑α) is 
one of  these a proinflammatory cytokine that can 
trigger a cascade of  events and lead to PTD.[2,16] 
Expression of  cytokines such as TNF‑α is also 
under genetic control.[17]
It has been reported that a genetic variant single 
nucleotide polymorphism (SNP) in the promoter 
region of  TNF‑α gene at –308 (a G/A transition 
resulting in TNF‑αamino acid (AA) or genotyping 
assays (GA) genotypes) may be associated with 
increased activation of  the TNF‑α gene compared 
with the GG genotype.[18‑20]
Given the common genetic background of  PTD 
and TNF‑α expression, a number of  studies have 
been performed to investigate the role of  genetic 
variation at the level of  SNPs within genes that 
regulate the inflammatory response, to determine 
whether there is an association between this 
genetic variations and predisposition to PTD in 
women or not. Although large‑scale studies have 
been conducted to assess the association of  the 
G308A polymorphism of  TNF‑α with PTD, no 
strong convincing evidence of  association has been 
found and this hypothesis remains controversial.[2]
This study was designed to search for an 
association between PTD and maternal or fetal 
SNP in TNF‑α −308 gene.
METHODS
Study population and design
After approval of  the study by the ethic committee 
of  Shahrekord University of  Medical Sciences and 
obtaining informed consent, this cross‑sectional 
study was performed on mothers who were referred 
to the Hajar hospital for delivery and their infants. 
This investigation was performed in Shahrekord, 
Iran, between March 2010 and April 2012.
Using convenience sampling method, pregnant 
women aged between 18 and 35 years with a 
gestational age (GA) between 28 and 42 weeks 
were included in this study.
Exclusion criteria were any history of  cervical 
incompetency, polyhydramnios, preeclampsia, 
vaginal bleeding during pregnancy, fetal 
abnormality, cord or placental abnormalities, 
psychological problems, diabetes or other chronic 
cardiac, kidney, pulmonary or collagen vascular 
diseases.
According to the gestational age at the time of  
delivery, women who met the study criteria were 
allocated to term (control) and preterm (case) 
groups.
Last menstrual period date confirmed 
by ultrasound dating was used to determine 
GA genotype. Mothers with preterm 
contractions (presence of  at least 2 regular uterine 
contractions per 10 min combined with documented 
cervical changes at GA of  <36
0
7
 weeks) at the time 
of  hospital admission for delivery were assigned to 
the case group and mothers with the normal labor 
and delivery (GA >37
0
7
 weeks) were assigned to 
the control group.
Subjects with GA between36
1
7
 and 36
6
7
 weeks 
were excluded to avoid the potential ambiguity of  
GA in this range.
Finally, a total of  135 women and their infants 
were recruited (71 in the term group and 64 in the 
preterm group).
Blood sampling and laboratory assays
For genotyping, a maternal peripheral blood 
sample and a fetal cord blood sample were taken. 
Blood samples of  5 ml were collected in 15 ml 
falcon tubes already containing 60 μl ethylene 
diamine tetra acetic acid (0.5 molar). All blood 
samples were frozen at −20°C for 24 h before 
polymerase chain reaction (PCR) and genotyping.
The sequence of  the primer was 
forward (5’‑TCCAGACTTTGAGACACG‑3’) and 
reverse (5’‑GGGCGATTACAGACAACT‑3’).
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According to the standard protocols, 
deoxyribonucleic acid (DNA) was extracted from 
blood samples by the phenol‑chloroform method 
using lysis buffer (Tris‑HCl10 ml, sucrose, MgCl
2
, 
5ml, tryptone X10, 10 ml.
The PCR was carried out in 0.25 ml tubes 
containing 100 ng sample of  DNA, 4 mmol 
1x‑PCR buffer (500 mmolKCl, Tris‑HCl with 
PH: 8.4 and 200 mmolAmS), MgCl
2
, 3 mmol, 
dNTPS: Deoxy ribo Nucleotide Triphosphates, 
(dTTP = Deoxy Thymidine Triphosphate, dATP 
Deoxy Adenosine Triphosphate, dGTP Deoxy 
Guanosine Triphosphate, dCTP Deoxy Cytidine 
Triphosphate) 0.2 mmol/l, DNA Taq polymerase 
0.5 mL and primers Cycling was performed at 
95°C for 5 min; then for 34 cycles of  94°C, for 
50 s (denaturation), 60°C for 50 s (annealing) and 
72°C for 30 s (extension); and finally for 5 min at 
72°C (final extension).
Then, 2.5 μl of  PCR amplification products 
was mixed with 0.5 μl of  loading dye and was 
electrophoresed on 5% polyacrylamide gels. Silver 
staining was used to detect proteins. In order to 
digestion of  PCR products, they were mixed with 
1 μl of  Tango buffer and 0.5 μl of  NCo1 enzyme 
for 3 h at 37°.
At this stage, 5 μl of  digested products was 
mixed with 4 μl of  loading dye and the sample 
was assessed using the polyacrylamide gel 
electrophoresis and silver staining [Figure 1]. 
Finally, TNF‑α −308 genotype and alleles were 
determined.
Statistical analysis
Data was analyzed by the Statistical Package 
for the Social Sciences (SPSS) 20.0 (SPSS Inc., 
Chicago, IL, USA) using independent t‑test and 
Chi‑square. P < 0.05 were considered statistically 
significant.
RESULTS
Baseline data
Mean of  GA and neonatal birth weight was 
significantly lower in the case group. However, 
there was no significant difference between 2 groups 
regarding other baseline characteristics [Table 1].
TNF‑α−308 polymorphism
Only 1 (1%) mother in the control group and 
2 (3%) mothers in the case group had GA genotype, 
which was not significantly different (P = 0.46).
All cord samples in both groups had GG 
genotype except 1 (1.5%) sample in the case group, 
Table 1: Comparison of baseline characteristics between 2 groups
Baseline characteristics Case group (n=64) Control group (n=71) P value
Maternal age (year) 27.44±5.11 27.76±5.80 0.30
Maternal BMI (kg/m2) 28.24±3.87 29.01±4.30 0.38
History of infection during pregnancy (%) 25 (39) 26 (36) 0.93
Smoking 3 (5) 2 (3) 0.77
Gestational age (weeks) 34.30±2.60 39.01±0.97 <0.0001
Delivery method (NVD/CS) (%) 23 (36)/41 (64) 23 (32)/48 (68) 0.67
Neonate gender (male/female) (%) 29 (45)/35 (55) 31 (43)/40 (57) 0.54
Neonatal birth weight (g) 2278.33±655.94 3159.36±359.98 <0.0001
Data are presented as mean±SD or number (%) of subjects, n=Number of subjects in each group, BMI=Body mass index, 
NVD=Natural vaginal delivery, CS=Cesarean section
Figure 1: Polyacrylamide gel electrophoresis demonstrating 
allelic variants of the tumor necrosis factor alpha −308 
polymorphism. White arrow: Mutation, red arrow: Mutation, 
blue arrow: Negative control, green arrow: Digested, yellow 
arrow: Positive control (uncut)
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which had GA genotype. This difference was not 
statistically significant as well (P = 0.47).
Characteristics of  mothers and neonates with 
GA genotype are presented in Table 2.
DISCUSSION
In spite of  much effort and extensive research 
over the past decades, PTD remains an important 
issue in perinatal care. Depending on the population, 
PTD may occur in 5‑10% of  pregnancies and cause 
serious perinatal morbidity and mortality.[21]
Several observations suggest that women may 
have a genetic pre‑disposition for PTD. Some 
investigators have reported an association between 
elevated levels of  TNF‑α concentration in maternal 
blood and/or amniotic fluid and PTD.[12,22‑25] On 
the other hand, TNF‑α gene production is partly 
regulated at transcriptional level. The position −308 
in TNF‑α gene may have a normal guanine (G) 
allele or have a variant adenine (A) allele.[2]
It has been shown that G308A transition in the 
promoter region of  TNF‑α gene results in TNF‑α 
AA or GA genotypes that may induce higher levels 
of  TNF‑α gene transcription and activation[20,22] 
and cause disease susceptibility in the human 
subjects.[2]
Based on the combination of  the above evidence, 
some investigators have hypothesized that preterm 
labor may be associated with genetic mutations in 
TNF‑α gene at some positions such as −308.
A number of  studies suggest that this genotype 
variant may affect the likelihood of  PTD,[26‑30] but 
some others reject this association.[9,22,31]
Present study demonstrated that despite higher 
frequency of  GA mutation in TNF‑α gene at −308 
position in mothers and neonates with PTD, 
this association was not statistically significant. 
Our findings are consistent with several previous 
studies, which did not find such association.
Menon et al., performed a meta‑analysis of  
available evidence and concluded that there is no 
statistically significant association between a SNP 
in the TNF‑α gene PTD.[20]
Dizon‑Townson et al. also compared the 
frequencies of  TNF T1 or TNF T2 allele between 
women or fetuses delivered preterm with the 
control group or previously published allele 
frequencies and reported that the frequency of  
TNF‑α promoter mutation is not increased in 
either women or fetuses delivered pretermly.[22]
In addition, in vitro assays that used −308 
SNP[18,19] and studies that used cells derived from 
subjects with various TNF‑α −308 genotypes 
showed inconsistent results[33,34] and raised doubts 
about the functional significance of  −308 SNP.[20] 
The presence of  other SNPs in the TNF‑α gene 
and/or variation in other genes that can modify 
expression, translation and post‑translational 
modification of  TNF‑α gene could be the probable 
causes of  this condition.[35,36]
A study performed by Moura et al. suggests that 
the combination of  TNF‑α, including interferon‑γ 
and interleukin‑6 maternal gene polymorphisms 
might contribute to susceptibility to PTD, not the 
TNF‑α polymorphism alone.[3]
Because immunological response is most 
probably the result of  the interaction between 
several polymorphic genes,[37] it is not be surprising 
to find a significant association between a single 
polymorphism and an event such as PTD.
Therefore, it would be logical to investigate 
the combination of  various polymorphisms in 
different genes to make an appropriate assessment, 
the role ofpolymorphic genes in the pathogenesis 
of  PTD.[38]
Table 2: Maternal and fetal characteristics of subjects with GA genotype
Maternal 
and fetal 
characteristics
TNF‑α‑308 
genotype
Group Maternal 
age
Maternal 
BMI
Gestational 
age
Delivery 
method
History of 
infection 
during 
pregnancy
Smoking Neonatal 
birth 
weight
Neonate 
gender
Maternal Fetal
Case-1 GA GG Case 19 25.15 36 NVD + (UTI) - 2200 Female
Case-2 GA GG Case 24 24.02 35 NVD - - 2350 Female
Case-3 GA GG Control 24 26.14 40 NVD - - 3200 Female
Case-4 GG GA Case 24 22.31 28 c/s + - 800 Male
BMI=Body mass index, NVD=Natural vaginal delivery, UTI=Urinary tract infection, GA=Genotyping assays, 
TNF‑α=Tumor necrosis factor alpha
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CONCLUSION
In summary, we conclude that there is no 
significant association between PTD and either 
maternal or fetal TNF‑α −308 polymorphism and 
frequency of  GA mutation is not significantly 
increased in mothers and neonates delivered 
preterm. It means that the presence of  this 
mutation by itself  does not modify the overall 
risk of  PTD. Investigations on the combination 
of  various polymorphisms in different genes are 
recommended to achieve more accurate results.
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